First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
=========================================================================================================================================================

* Yixin Zhou
* Zuan Lin
* Xuanye Zhang
* Chen Chen
* Hongyun Zhao
* Shaodong Hong
* Li Zhang